Investeringsidéer
Bläddra bland alla aktier
Marknader
Investeringsidéer
›
Leverage Leaders
Redigera skärmdump
Få ny aktievarning
Leverage Leaders
Resultat
86
2 ny
🇺🇸 US Marknad
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
86 Företag
2 nya företag senast 7d
Företag
Senaste pris
7D Återkomst
1 års avkastning
Marknadsvärde
Analytikernas mål
Värdering
Tillväxt
Avkastning på aktier
STVN
Stevanato Group
US$22.38
3.1%
-0.09%
US$6.2b
US$24.83
PE
39.0
E
18.3%
0.3%
TRVI
Trevi Therapeutics
US$17.92
-4.7%
124.0%
US$2.6b
US$28.18
PB
7.9
E
-4.1%
n/a
NRIX
Nurix Therapeutics
US$26.71
-3.9%
179.7%
US$2.8b
US$33.50
PS
75.4
E
-14.5%
n/a
PCVX
Vaxcyte
US$61.09
-3.5%
100.0%
US$9.1b
US$109.00
PB
3.3
E
47.7%
n/a
ACAD
ACADIA Pharmaceuticals
US$29.58
-2.1%
11.3%
US$5.3b
US$34.00
PE
13.4
E
15.7%
n/a
ADMA
ADMA Biologics
US$9.63
-4.2%
-44.2%
US$2.2b
US$17.00
PE
12.8
E
19.6%
n/a
EXEL
Exelixis
US$56.10
3.1%
45.7%
US$14.1b
US$53.00
PE
16.2
E
12.0%
n/a
CORT
Corcept Therapeutics
US$119.80
0.7%
71.8%
US$13.4b
US$141.00
PE
238.6
E
43.0%
n/a
GPCR
Structure Therapeutics
US$49.35
-8.8%
159.7%
US$3.6b
US$104.77
PB
2.6
E
44.4%
n/a
RAPP
Rapport Therapeutics
US$52.50
7.0%
250.7%
US$2.5b
US$62.05
PS
125.9
E
-15.5%
n/a
KNSA
Kiniksa Pharmaceuticals International
US$78.68
-2.6%
133.5%
US$6.3b
US$98.00
PE
76.1
E
38.0%
n/a
CDNA
CareDx
US$50.96
9.6%
283.4%
US$2.6b
US$52.33
PE
23.7
E
-51.0%
n/a
IDYA
IDEAYA Biosciences
US$41.58
7.0%
66.3%
US$4.1b
US$52.15
PS
17.1
E
27.0%
n/a
UTHR
United Therapeutics
US$516.68
-2.4%
69.2%
US$22.2b
US$664.33
PE
16.9
E
15.6%
n/a
REGN
Regeneron Pharmaceuticals
US$814.79
-3.1%
38.8%
US$83.2b
US$840.43
PE
18.8
E
12.0%
0.5%
HTSU.Y
Hisamitsu Pharmaceutical
US$4.55
0%
n/a
US$8.2b
n/a
PE
10.6
n/a
1.3%
SUPN
Supernus Pharmaceuticals
US$44.88
-7.5%
-0.4%
US$2.6b
US$61.75
PS
3.1
E
61.3%
n/a
ELVN
Enliven Therapeutics
US$60.87
2.5%
194.3%
US$4.5b
US$73.90
PB
5.0
E
-16.3%
n/a
ERAS
Erasca
US$19.15
6.0%
1,112.0%
US$6.2b
US$23.50
PB
18.5
E
5.0%
n/a
SYRE
Spyre Therapeutics
US$93.61
-14.1%
446.1%
US$9.5b
US$119.71
PB
8.6
E
-18.2%
n/a
TECH
Bio-Techne
US$72.38
-0.1%
28.7%
US$11.3b
US$70.73
PE
62.4
E
15.0%
0.4%
APGE
Apogee Therapeutics
US$134.95
0.2%
257.1%
US$10.2b
US$134.85
PB
8.5
E
1.6%
n/a
STOK
Stoke Therapeutics
US$33.09
0.2%
71.5%
US$2.2b
US$46.46
PS
77.4
E
44.8%
n/a
GRAL
GRAIL
US$79.59
7.6%
136.7%
US$3.7b
US$72.38
PS
21.5
E
-6.7%
n/a
Page 1 of 3
Instrumentpanel
Portföljer
Bevakningslista
Gemenskap
Upptäck
Skärm